Anebulo Pharmaceuticals Inc

NASDAQ ANEB

Download Data

Anebulo Pharmaceuticals Inc Price to Book Ratio (P/B) on June 03, 2024: 11.13

Anebulo Pharmaceuticals Inc Price to Book Ratio (P/B) is 11.13 on June 03, 2024, a 123.47% change year over year. The price to book ratio compares the market price per share of a company's stock to its book value per share. It is calculated by dividing the market capitalization by the shareholders' equity minus treasury stock, divided by the number of outstanding shares. This ratio provides insights into how the market values a company relative to its book value. A ratio above 1 indicates the market values the company more than its book value, suggesting positive market sentiment.
  • Anebulo Pharmaceuticals Inc 52-week high Price to Book Ratio (P/B) is 15.57 on May 10, 2024, which is 39.88% above the current Price to Book Ratio (P/B).
  • Anebulo Pharmaceuticals Inc 52-week low Price to Book Ratio (P/B) is 4.12 on June 26, 2023, which is -62.99% below the current Price to Book Ratio (P/B).
  • Anebulo Pharmaceuticals Inc average Price to Book Ratio (P/B) for the last 52 weeks is 8.13.
NASDAQ: ANEB

Anebulo Pharmaceuticals Inc

CEO Dr. Joseph F. Lawler M.D., Ph.D.
IPO Date May 7, 2021
Location United States
Headquarters 1415 Ranch Road 620 South, Lakeway, TX, United States, 78734
Employees 2
Sector Healthcare
Industry Biotechnology
Description

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction. The company's lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist, which is in a Phase II clinical trial to address the unmet medical need for a specific antidote for ACI. Anebulo Pharmaceuticals, Inc. was incorporated in 2020 and is based in Lakeway, Texas.

Similar companies

ADAG

Adagene Inc

NA

NA

ACRV

Acrivon Therapeutics Inc. Common Stock

NA

NA

AVTE

Aerovate Therapeutics Inc

NA

NA

ANTX

AN2 Therapeutics Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email